#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	8138	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2038	670.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1624	1624	T	776	T	435	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	8138	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2038	670.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1358	1358	C	964	C	540	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	13900	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3723	606.1	0	.	n	.	0	A9G	SNP	9	9	A	396	396	G	613	G	362	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	13900	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3723	606.1	0	.	n	.	0	T695C	SNP	695	695	T	1082	1082	C	844	C	461	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	13900	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3723	606.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2358	2358	C	631	C	354	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	13900	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3723	606.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2432	2432	A	685	A	389	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	13900	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3723	606.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2984	2984	C	829	C	486	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	504	folP	855	855	99.88	folP.l15.c4.ctg.1	1490	61.0	1	SNP	p	R229S	1	.	.	685	687	AGC	929	931	AGC	65;65;63	A;G;C	38;39;35	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	0	.	p	.	0	T243I	NONSYN	727	729	ACA	830	832	ATA	78;73;55	A;T;A	51;48;39	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	0	.	p	.	0	M250I	NONSYN	748	750	ATG	851	853	ATA	56;56;56	A;T;A	36;37;37	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	0	.	p	.	0	L770F	NONSYN	2308	2310	TTG	2411	2413	TTT	5;5;5	T;T;T,G	4;3;0,3	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	1	SNP	p	S91F	0	.	.	271	273	TCC	374	376	TCC	84;85;85	T;C;C	50;50;54	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	1	SNP	p	D95N	0	.	.	283	285	GAC	386	388	GAC	97;101;101	G;A,T;C	59;60,1;60	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	2357	99.62	gyrA.l15.c4.ctg.1	2460	80.9	1	SNP	p	D95G	0	.	.	283	285	GAC	386	388	GAC	97;101;101	G;A,T;C	59;60,1;60	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	590	99.66	gyrA.l15.c4.ctg.2	853	46.8	0	.	p	.	0	S755G	NONSYN	2263	2265	AGC	102	104	GGC	6;6;6	G,A;G;C	0,2;2;2	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	1432	gyrA	2751	590	99.66	gyrA.l15.c4.ctg.2	853	46.8	0	.	p	.	0	S763A	NONSYN	2287	2289	TCC	126	128	GCC	7;9;9	G,T;C;C	0,3;5;4	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	354	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1258	50.1	0	.	p	.	0	T169P	NONSYN	505	507	ACG	778	780	CCG	50;50;50	C;C;G	25;26;27	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	354	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1258	50.1	1	SNP	p	G45D	0	.	.	133	135	GGC	406	408	GGC	103;105;105	G;G;C	60;59;60	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	302	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	690	70.0	0	.	n	.	0	.206T	INS	206	206	T	399	399	T	115	T	72	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1679	1681	GCC	77;77;71	G;C;C	45;46;41	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1721	1723	GCA	78;80;80	G;C;A	41;43;42	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	1	SNP	p	D86N	0	.	.	256	258	GAC	674	676	GAC	95;95;95	G;A;C	57;53;55	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	1	SNP	p	S87R	0	.	.	259	261	AGT	677	679	AGT	96;100;101	A,C;G;T	54,1;60;56	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	1	SNP	p	S87I	0	.	.	259	261	AGT	677	679	AGT	96;100;101	A,C;G;T	54,1;60;56	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	1	SNP	p	S87W	0	.	.	259	261	AGT	677	679	AGT	96;100;101	A,C;G;T	54,1;60;56	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1264	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2932	71.2	1	SNP	p	S88P	0	.	.	262	264	TCC	680	682	TCC	101;100;99	T;C;C	58;57;58	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	1298	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2382	93.2	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1428	1430	GGT	75;75;75	G;G;T,G	47;46;44,1	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1061	1063	GCA	156;157;157	G;C;A	90;88;90	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1064	1066	ATC	159;159;159	A;T;C	90;92;92	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1076	1078	GTG	159;159;159	G;T;G	92;87;90	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1076	1078	GTG	159;159;159	G;T;G	92;87;90	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1580	1582	ACC	89;90;88	A;C;C	55;56;56	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1634	1636	GCG	77;79;81	G;C,G;G	44;45,1;49	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1634	1636	GCG	77;79;81	G;C,G;G	44;45,1;49	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1757	1759	GGT	105;106;106	G;G;T	61;63;61	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1766	1768	GGC	93;93;93	G;G;C	56;56;55	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1452	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2024	117.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1784	1786	CCG	87;87;87	C,T;C;G,T	49,1;53;50,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	2472	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3083	122.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1684	1686	CTG	98;95;95	C;T;G	57;52;54	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	624	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1759	61.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	270	272	GGC	65;65;65	G;G;C	36;36;37	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	624	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1759	61.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	452	452	C	37	C	25	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	269	271	ATG	78;76;76	A;T;G	47;44;45	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	E41K	NONSYN	121	123	GAA	338	340	AAA	75;75;75	A;A;A	43;43;44	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	359	361	GGA	77;77;78	G;G;A	47;45;46	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	V75I	NONSYN	223	225	GTT	440	442	ATT	73;73;73	A;T;T	43;44;43	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	T89S	NONSYN	265	267	ACC	482	484	AGC	81;81;76	A;G;C	46;47;42	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	V98I	NONSYN	292	294	GTC	509	511	ATC	72;72;70	A;T;C	40;39;39	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	.	MULTIPLE	358	359	AA	574	575	CG	59;59	C;G	37;35	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	.	MULTIPLE	361	362	GA	577	579	CAG	59;59;59	C;A;G	37;36;37	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	N122K	NONSYN	364	366	AAC	581	583	AAA	59;59;60	A;A;A	33;36;38	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	608	610	TAT	66;69;69	T;A;T	42;44;43	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	N134E	NONSYN	400	402	AAT	617	619	GAG	68;68;69	G;A;G	40;41;42	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	V135F	NONSYN	403	405	GTG	620	622	TTT	69;69;69	T;T;T	42;43;42	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	635	637	AAA	70;70;70	A,C;A;A	42,1;44;44	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	K143E	NONSYN	427	429	AAA	644	646	GAA	70;73;73	G;A;A	43;46;45	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	668	670	GCA	78;78;78	G;C;A	49;45;50	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	T213S	NONSYN	637	639	ACA	854	856	TCA	109;114;116	T;C;A	60;64;65	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	974	976	CAA	95;96;96	C;A;A	57;56;58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	.	INDELS	760	762	ACA	978	982	ATCAA	96;94;92;92;92	A;T;C;A;A	55;52;56;56;55	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	.	INDELS	763	764	TG	985	987	AGT	90;89;89	A;G;T	56;55;54	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	A257D	NONSYN	769	771	GCT	992	994	GAT	91;91;93	G;A;T	56;56;58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1028	1030	AGC	89;88;88	A;G;C	55;51;54	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1100	1102	AGT	97;99;90	A;G;T	63;64;56	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1106	1108	GAC	89;90;95	G;A;C	56;55;59	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1109	1111	TAC	95;95;99	T;A;C	58;57;60	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	1	SNP	p	G120K	1	.	.	358	360	AAG	574	576	CGG	59;59;59	C;G;G	37;35;37	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	1	SNP	p	A121D	1	.	.	361	363	GAC	577	580	CGC	59;59;59	C;G;C	37;37;36	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	618	porB1b	1041	1041	96.09	porB1b.l15.c4.ctg.1	1597	68.8	1	SNP	p	D121N	0	.	.	361	363	GAC	577	580	CGC	59;59;59	C;G;C	37;37;36	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	T252S	NONSYN	754	756	ACC	43	45	AGC	6;6;6	A;G;C	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	L253V	NONSYN	757	759	TTG	46	48	GTG	6;6;6	G;T;G	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	S273T	NONSYN	817	819	TCG	106	108	ACT	12;12;12	A;C;T	6;6;6	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	D276S	NONSYN	826	828	GAT	115	117	AGT	10;10;10	A;G;T	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	K278D	NONSYN	832	834	AAA	121	123	GAC	10;10;12	G;A;C	5;5;6	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	124	126	TAC	12;12;12	T;A;C	6;6;6	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	E313A	NONSYN	937	939	GAA	226	228	GCA	4;4;4	G;C;A	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	N314D	NONSYN	940	942	AAC	229	231	GAC	4;4;4	G;A;C	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	50	porB3	990	229	93.45	porB3.l15.c4.ctg.2	238	9.2	0	.	p	.	0	F316I	NONSYN	946	948	TTC	235	237	ATC	2;2;2	A;T;C	1;1;1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3802	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4760	132.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1952	1954	CAT	162;162;162	C;A;T	95;96;95	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	314	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	830	64.1	1	SNP	p	V57M	1	.	.	169	171	ATG	447	449	ATG	113;111;112	A;T;G	63;61;60	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
